AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
29 Jan 2004 11:00 AM
RNS
Final Results - Part 2 of 2
29 Jan 2004 11:00 AM
RNS
Final Results - Part 1 of 2
29 Jan 2004 07:00 AM
RNS
Nexium NSAID
28 Jan 2004 09:00 AM
RNS
Notice of Results
23 Jan 2004 05:48 PM
RNS
Holding(s) in Company
22 Jan 2004 02:30 PM
RNS
Holding in Company
13 Jan 2004 07:00 AM
RNS
Seroquel
23 Dec 2003 03:15 PM
RNS
Exanta
23 Dec 2003 01:15 PM
RNS
Exanta
19 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
18 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
15 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
12 Dec 2003 09:30 AM
RNS
Prilosec Appeal Result
12 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
10 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
09 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
08 Dec 2003 07:01 AM
RNS
Exanta
08 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
04 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
02 Dec 2003 07:00 AM
RNS
Transaction in Own Shares
01 Dec 2003 07:00 AM
RNS
Purchase of Own Securities
28 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
27 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
24 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
20 Nov 2003 04:00 PM
RNS
Director Shareholding
19 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
18 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
17 Nov 2003 08:30 AM
RNS
Symbicort Turbuhaler
14 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2003 04:23 PM
RNS
Director Shareholding
13 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
11 Nov 2003 02:00 PM
RNS
Exanta
07 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
05 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
04 Nov 2003 07:00 AM
RNS
Purchase of Own Securities
31 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
30 Oct 2003 01:00 PM
RNS
Seroquel Approvable Letter
30 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
29 Oct 2003 04:53 PM
RNS
Director Shareholding
29 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
27 Oct 2003 07:00 AM
RNS
Purchase of Own Securities
23 Oct 2003 11:00 AM
RNS
3rd Quarter Results -Part 2/2
23 Oct 2003 11:00 AM
RNS
3rd Quarter Results -Part 1/2
23 Oct 2003 09:33 AM
RNS
Correction to Notice
22 Oct 2003 09:00 AM
RNS
Notice of 3rd Quarter Results
16 Oct 2003 01:03 PM
RNS
Collaboration with Abgenix
13 Oct 2003 08:30 AM
RNS
Seroquel
02 Oct 2003 01:00 PM
RNS
Annual Business Review
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings